ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

DCPC Board Oks Concept For Three New Grant Programs, Three Contracts

May 22, 1987

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

Treatment Division Outlines Future Program Areas

January 24, 1975

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012